User Reviews for Ruzurgi
Reviews may be moderated or edited before publication to correct grammar and spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest in the medication will not be published. As reviews and ratings are subjective and self-reported, this information should not be used as the basis for any statistical analysis or scientific studies.
For Lambert-Eaton Myasthenic Syndrome: “For me this drug was like a miracle drug. I could barely walk and after a short time after taking the medicine I walked just about normal.”
For Lambert-Eaton Myasthenic Syndrome: “I have been on ruzurgi (which use to be called 3,4 DAP) since 2014 and it is a miracle drug. I could barely walk and when I took this drug I was walking nearly normal after 20 minutes. In 2018, Catalyst patented firdapse and we were forced to go on it in Jan 2019. I had so many side effects from firdapse that I never had on ruzurgi. Luckily for me, ruzurgi got approved for children from ages 6-17 and my doctor can now prescribe it off-label. I was never so happy in my life to get back the ruzurgi.”
This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.
More about Ruzurgi (amifampridine)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- 2 Reviews
- Drug class: cholinergic muscle stimulants
- FDA Approval History
- Other brands